TRANSGENE Reports First Quarter 2014 Financial Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Regulatory News:

Transgene (Paris:TNG) (Euronext Paris: FR0005175080) today issued its quarterly financial report1 as of March 31, 2014 (first quarter of 2014).

Operating revenue:

The following table summarizes the first quarter operating revenue for 2014 compared to the same period in 2013:

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC